Red tape for firms is price of leaving 'anti-science' EU, Gove says

© Reuters. Britain’s Chancellor of the Duchy of Lancaster Michael Gove arrives at the weekly cabinet meeting

LONDON (Reuters) – Britain should celebrate its looming break from the “anti-science and anti-innovation” approach of the European Union even if it costs its industry more in red tape, the government’s Brexit supremo Michael Gove said on Thursday.

Gove was asked in the House of Commons by an opposition lawmaker why companies in the chemicals industry should have to stump up an extra 1 billion pounds in the midst of an economic crisis to duplicate regulation that it already has with the EU.

Gove, the minister handling Brexit divorce issues for Britain and one of the leading advocates for the break with Brussels, said extra red tape was the price of securing autonomy and independence to become more competitive in the future.

“It’s an inevitable consequence of leaving the European Union Single Market and Customs Union and freeing ourselves from the jurisdiction of the Court of Justice of the European Union that we do have to have our own regulatory systems in place,” he said.

“One of the great prizes of leaving the European Union is that when it comes to life sciences and other areas we will be free from the often anti-science and anti-innovation approach that the EU has had hitherto.”

Britain’s chemicals industry, which includes companies such as Ineos, Johnson Matthey (LON:), Croda and Synthomer, is bound to the EU by an especially dense web of laws and safety standards, and an EU products registry called Reach.

READ  How lashes became big business

The lawmaker asking the question, Labour’s Hilary Benn, said his parliamentary select committee had been told by representatives of the industry that the cost of registering all chemicals under a new UK Reach system would be around 1 billion pounds.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.


Leave a Reply